ANIX
Anixa Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.83
-0.03 ▼ -1.05%
🌙 3월 13일 6:51 PM ET (한국 3/14 07:51)
$2.94
+0.11 ▲ +3.89%
| Index | - | P/E | - | EPS (ttm) | -0.32 | Insider Own | 5.41% | Shs Outstand | 0.03B | Perf Week | -0.7% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | 2.02% | Insider Trans | 0.55% | Shs Float | 0.03B | Perf Month | -0.35% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | -0.09 | Inst Own | 17.01% | Short Float | 3.64% | Perf Quarter | -44.83% |
| Income | -0.01B | P/S | - | EPS this Y | 4.35% | Inst Trans | 1.1% | Short Ratio | 5.56 | Perf Half Y | -4.07% |
| Sales | 0.00B | P/B | 6.28 | EPS next 5Y | 1.14% | ROA | -60.39% | Short Interest | 1.15M | Perf YTD | -9.29% |
| Book/sh | 0.45 | P/C | 6.68 | EPS past 3/5Y | 9.05% 5.67% | ROE | -62.61% | 52W High | -48.14% ($5.46) | Perf Year | 0.71% |
| Cash/sh | 0.42 | P/FCF | - | Sales past 3/5Y | - | ROIC | -67.69% | 52W Low | 21.41% ($2.33) | Perf 3Y | -32.3% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 19.02% | Gross Margin | - | Volatility(W/M) | 6.2% 5.45% | Perf 5Y | -51.54% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.17 | Perf 10Y | -4.07% |
| Dividend Ex-Date | - | Quick Ratio | 12.18 | EPS Q/Q | 21.94% | Profit Margin | - | RSI (14) | 41.65 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.18 | Sales Q/Q | - | SMA20 | -3.08% ($2.92) | Beta | 0.53 | Target Price | $8.67 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/01/07 | SMA50 | -6.71% ($3.03) | Rel Volume | 0.33 | Prev Close | $2.86 |
| Employees | 4 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 9.09% - | SMA200 | -17.56% ($3.43) | Avg Volume(3M) | 0.21M | Price | $2.83 |
| IPO | 1983/10/7 | Option/Short | Yes/Yes | Trades | 356 | Volume | 67,935 | Change | -1.05% |
뉴스 로딩 중...